Acute and Subclinical Myocardial Injury in COVID-19

Valentina L. Crudo, Ahmed I. Ahmed, Eilidh L. Cowan, Dipan J. Shah, Mouaz H. Al-Mallah, Maan Malahfji

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Coronavirus disease 2019 (COVID-19) is a global pandemic that, at the time of this writing, has led to 178,000,000 cases worldwide and more than 3,875,000 deaths. Cardiovascular complications of COVID-19 have become the focus of investigation after many hospitalized COVID-19 patients-with or without established cardiovascular disease-incurred clinical or subclinical myocardial injury, including isolated biomarker elevations, myocardial infarction, arrhythmia, heart failure, myocarditis, and cardiogenic shock. In this review, we highlight the most recent evidence of the prevalence and potential etiologies of acute and subclinical myocardial injury in COVID-19 patients.

Original languageEnglish (US)
Pages (from-to)22-30
Number of pages9
JournalMethodist DeBakey cardiovascular journal
Issue number5
StatePublished - 2021


  • COVID-19
  • cardiovascular disease
  • coronavirus
  • myocardial injury
  • myocarditis

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Acute and Subclinical Myocardial Injury in COVID-19'. Together they form a unique fingerprint.

Cite this